Howe & Rusling Inc Sorrento Therapeutics, Inc. Transaction History

Howe & Rusling Inc

  • $1.16 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.51 - $2.88 $302 - $576
-200 Reduced 9.09%
2,000 $3,000
Q2 2022

Aug 15, 2022
BUY
$1.24 - $2.33 $248 - $466
200 Added 10.0%
2,200 $4,000
Q1 2022

May 10, 2022
BUY
$2.0 - $4.9 $2,000 - $4,900
1,000 Added 100.0%
2,000 $5,000
Q3 2020

Nov 06, 2020
BUY
$6.17 - $18.82 $6,170 - $18,820
1,000 New
1,000 $11,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.37M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email